Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M.V. Longobardo Polanco"'
Autor:
A. Salmerón-García, N. Navas Iglesias, J. Cabeza Barrera, A. Lario Simon, M.V. Longobardo Polanco, R. Ortega López, L.F. Capitán Vallvey
Publikováno v:
European Journal of Hospital Pharmacy. 19:83.2-83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86c454e19fc2f8f7ee8c30391fe50a37
https://doi.org/10.1136/ejhpharm-2012-000074.83b
https://doi.org/10.1136/ejhpharm-2012-000074.83b
Autor:
R. Ortega López, L.F. Capitán Vallvey, N Navas Iglesias, Antonio Salmerón-García, M.V. Longobardo Polanco, A. Lario Simon, J. Cabeza Barrera
Publikováno v:
European Journal of Hospital Pharmacy. 19:149.1-149
Background The active substance of Remicade is infliximab. It is a chimeric human-murine monoclonal antibody directed against tumour necrosis factor α (TNFα), manufactured from a recombinant cell line. Remicade is presented as powder for concentrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fba099914ed12f0e59132dd71cd62d7
https://doi.org/10.1136/ejhpharm-2012-000074.170
https://doi.org/10.1136/ejhpharm-2012-000074.170